Kotak Healthcare Fund Regular Growth

+

Equity
Sector - Healthcare
Rating N.A.
Plan

14.01 -0.03 (-0.23%) NAV as on 06 Dec, 2024

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)405.71
CAGR 0.00%
Exit Load1.00%
Expense ratio2.39%
CategoryEquity
Min Investment100
Min SIP100
Launch Date2023-12-11

Asset Allocation

Holdings As On - 08 December 2024

Holdings

Sectors

Name
Value (Cr)
Holding %

Cipla
28.71
7.08%

Divis Laboratories
21.21
5.23%

Jubilant Pharmova
16.97
4.18%

Aurobindo Pharma
16.90
4.16%

Lupin
15.75
3.88%

Peer Comparison

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .

The Kotak Healthcare Fund Regular Growth has an AUM of 405.71 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.39%. The minimum investment in Kotak Healthcare Fund Regular Growth is Rs 100 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are - & - respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Divis Laboratories & Max Healthcare Institute.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

Some of the similar funds are Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, ITI Pharma and Healthcare Fund Regular Growth. Kotak Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.